Reviva Pharmaceuticals Holdings earnings were -$29.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest RVPH earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$6.3M, down 25.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RVPH reported annual earnings of -$29.9M, with -23.8% growth. The next RVPH earnings date is May 12, 2025.
Reviva Pharmaceuticals Holdings Earnings Reports & History FAQ
What were Reviva Pharmaceuticals Holdings's earnings last quarter?
Reviva Pharmaceuticals Holdings (NASDAQ: RVPH) reported Q4 2024 earnings per share (EPS) of -$0.15, up 54.55% year over year. Total RVPH earnings for the quarter were -$6.26 million. In the same quarter last year, Reviva Pharmaceuticals Holdings's earnings per share (EPS) was -$0.33.
When does Reviva Pharmaceuticals Holdings report earnings?
The next RVPH earnings date is Invalid Date. Add RVPH to your watchlist to be reminded of Reviva Pharmaceuticals Holdings's next earnings date.
What was RVPH's earnings growth in the past year?
As of Reviva Pharmaceuticals Holdings's earnings date in Q2 2025, Reviva Pharmaceuticals Holdings's earnings has grown year over year. RVPH earnings in the past year totalled -$29.92 million.
Is Reviva Pharmaceuticals Holdings profitable or losing money?
As of the last Reviva Pharmaceuticals Holdings earnings report, Reviva Pharmaceuticals Holdings is currently losing money. Reviva Pharmaceuticals Holdings's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$29.92 million, a 23.79% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.